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Objective: To study the bactericidal activity of P-lactam antibiotics (imipenem, cefepime, cefpirome) alone or in 
combination with a P-lactamase inhibitor (sulbactam) in the presence or absence of aminoglycoside (amikacin or 
isepamicin) against Klebsiella pneumoniae strains producing extended-spectrum p-lactamases (ESBLs). 
Methods: We characterized 10 strains by means of analytic isoelectric focusing and pulsed-field gel electrophoresis. 
The ESBLs produced by these strains were derived from either TEM (TEM-I, TEM-2) or SHV-1. The killing-curve method 
was used for this bacterial investigation. Bacteria (final inoculum 5 x105 CFU/mL) were incubated with antibiotics at 
clinical concentrations obtained in vivo. 
Results: All the combinations with cefepime or cefpirome + sulbactam were bactericidal, with a 4 log,, decrease being 
obtained within 6 h without regrowth at 24 h, whereas imipenem alone, and combinations, gave a bactericidal effect 
within 6 h. The two cephalosporins alone decreased the inoculum of 4 loglo at 6 h but regrowth was observed at 24 h. 
When the aminoglycoside was added, this bactericidal effect was obtained within 3 h with amikacin and within 1 h with 
isepamicin. 
Conclusions: Cefepime + sulbactam or cefpirome + sulbactam may be an alternative to imipenem for the treatment 
of patients with ESBL-producing K. pneumoniae. Aminoglycosides are often associated in nosocomial infections due to 
ESBL-producing K. pneumoniae: isepamicin acted faster than amikacin, but both worked well. To conclude, it may be 
prudent to avoid extended-spectrum cephalosporins as single agent when treating serious infections due to ESBL- 
producing K. pneumoniae. Addition of a P-lactamase inhibitor such as sulbactam t aminoglycoside is advisable to avoid 
failure of treatment. 
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INTRODUCTION 
A iiunibcr of extended-spectrum cephalosporins have 
been marketed in recent y e m .  The main feature of 
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these compounds is their re1,itive resistance to hydro- 
ysis by Grani-negative p-lactaniases. However, there 
lime been strains reported xvitli trmTferable p-lactcimcues 
conferring resistance to estencied-spectruiii cephalo- 
sporins. especially for Klehsicllu prirurnorzinc [ 1-31, These 
new p-lactanlases caused decreased susceptibility to 
most penicillins, cephalosporins and nionobactams. 
with the notable exceptions of iniipenem, ~iieropeneiii 
and compounds which have a C:h or C : 7 a  metho? 
cubstituent (i.e. cefoxitin, cefotetan, moxalactani). Since 
their discovery in the mid-1 980s. about 30 plasmid- 
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mediated enzymes have been identified, most of them 
derived from TEM or SHV enzymes [4-61. These new 
P-lactaniases appear to have arisen by point mutation 
from TEM-1, TEM-2 and SHV-1. Even the phenotypic 
responses of antimicrobial tests give susceptibilities for 
these compounds (extended-spectrum cephalosporins), 
especially TEM-3 versus cefoxatime (CTX); the Anti- 
biogram Committee of the French Society for Micro- 
biology [7] recommends interpreting the strain as 
intermediate when an ESBL is detected. P-Lactamase 
inhibitors (clavulanic acid, sulbactam, tazobactam) 
inhibit the activity of these ESBLs and show a 
synergistic effect when associated with different hydro- 
lysable p-lactam compounds [8,9]. The prescription of 
an extended-spectrum cephalosporin alone in treat- 
ment of infection due to ESBL-producing K. pneu- 
rnoniae has failed in described cases [10,11]. This is why 
the aim of this investigation was to study the action of 
the new extended-spectrum cephalosporins (cefepime 
(FEP), cefpirome (CPO)) alone or in combination 
with a P-lactamase inhibitor (sulbactam (SUL)) versus 
imipenem (IMP) in the presence or absence of amino- 
glycosides (amikacin (AKN) or isepamicin (ISE)), 
against 10 non-repetitive strains of ESBL-producing 
K. pneumoniae. 
MATERIALS AND METHODS 
Strains and antibiotics 
Ten non-repetitive clinical strains of ESBL-producing 
K. pnewnoniae resistant to cekizidime and cefotaxime 
(CAZ-R, CTX-R) and susceptible to cefotetan, 
imipeneni and gentamicin (CTT-S, IMP-S, GT-S), 
were isolated from patients admitted to our hospital and 
selected for the study. The following antimicrobial 
agents of known potency 'were evaluated: CTX 
(Roussel-Diamant), CAZ (Glaxo), CTT (ICI Pharma), 
cefoxitin (FOX) (Merck Sharpe & Dohme-Chibret), 
GT (Schering-Plough), IMP (Merck Sharpe & 
Ilohme-Chibret), FEP (Bristol-Myers Squibb), CPO 
(Roussel-Diamant), SUL (Pfizer Inc.), AKN (Bristol- 
Myers Squibb) and ISE (Schering-Plough). 
MIC determination and aminoglycoside resistance 
phenotype 
MICs were determined by the agar dilution method 
as described by the Antibiogram Committee of the 
French Society for Microbiology [7] in cation-supple- 
inented Mueller-Hinton medium (Difco Laboratories, 
Detroit, Michigan). The inoculum was adjusted from 
an exponential-phase culture to give an initial concen- 
tration of 10' CFU/mL. After 18 h of incubation at 
37"C, MICs were determined as the lowest concen- 
tration that completely inhibited growth. With the kit 
described by Miller et a1 [12], the 12 aminoglycosides 
used allowed the aminoglycoside enzymatic resistance 
mechanism to be distinguished from aminoglycoside 
resistance phenotype, given that these enzymes have 
distinct substrate and resistance profiles. 
Killing-curve method 
Time kill curves were obtained according to Krogstad's 
method [ 131. The medium was cation-supplemented 
Mueller-Hinton broth. The exponential-phase inocu- 
lum was prepared by inoculating five colonies in 4 mL 
of Mueller-Hinton broth; it was incubated for 4 h at  
37OC in a shaking bath to give an initial inoculum 
of about 10sCFU/mL. Dilutions of that culture 
were then made in fresh medium to give 5 ~ 1 0 ~  to 
Tests were carried out in tubes containing 10 mL 
of culture with the required concentrations of anti- 
biotics. The same inoculum was added to antibiotic- 
free medium as a growth control. The cultures were 
incubated at  37OC in a shaking bath, and 100 pL from 
each tube was sampled at 1 h, 3 h, 6 h and 24 h, suitably 
diluted for subculture, and plated on agar using a spiral 
plating system to detect and avoid the carryover effect 
[14]. These timed subculture plates were then incub- 
ated at 37°C for 24 h and loglo CFU/mL of surviving 
bacterial cells was counted for each time, using surface 
viable counts. 
The bactericidal effect (decrease of 4 loglo) of p- 
lactam antibiotics alone or in combination was studied 
with an aminoglycoside at  the following concentra- 
tions: IMP, 8 mg/L; FEP, 32 mg/L; CPO, 32 mg/L; 
AKN, 16 mg/L; ISE, 16 mg/L. SUL was added at a 
concentration of 8 mg/L for each combination studed. 
Thus, the bactericidal effect (decrease of 4 loglo) of 
p-lactam antibiotics alone or in combination was 
studied with an aniinoglycoside at the superior break- 
point recommended by the Antibiogram Committee 
of the French Society for Microbiology [7]. Killing 
curves were then plotted. 
5 x lo6 CFU/mL. 
Analytic isoelectric focusing 
Extracts prepared by ultrasonic disintegration were 
applied on filter paper strips to commercially obtained 
polyacrylaniide gels containing anipholines with a pH 
range of 3.5-10 (LKB Products). Electrofocusing 
was done by the procedure recommended by the 
manufacturer with the LKB 21 17 Multiphor apparatus. 
p-Lactamases of known PI (TEM-1, 5.4; TEM-2, 
5.6; CTX-1, 6.3; SHV-1, 7.7) were focused in parallel 
with the extracts. The enzyme activities were located 
in the gels with chromogenic cephalosporin C M  32150 
[I]. 
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Pulsed-field gel electrophoresis [15] 
K. pneumoniae isolates grown overnight in 5 mL brain- 
heart broth infusion were adjusted to a density of 
10’ CFU/mL. Cells were pelleted by centrifugation at  
10 000 rev/min for 5 min at 4°C. Pelleted cells were 
washed with buffer (10 mM Tris-HC1, 1 M NaCI, 
pH 7.6) and resuspended in 1 nil of the same solution. 
Equal volumes of low-melting-point agarose (LKB, 
Bromma, Sweden) and bacterial suspension were 
mixed and molded in plugs at  4OC. Cells within the 
agarose plugs were lysed at 55°C for 48 h in 1 mL lysis 
buffer (0.5 M EDTA, 1% N-lauroyl-sarcosine, 1% 
proteinase K, pH 8). Agarose plugs were incubated 
twice at  42°C for 1 h with 1 mL TE-PMSF (10 mM 
Tris, 0.1 mM EDTA, 1 mM phenylmethylsulfonyl 
fluoride, pH 8) and then three times in Tris-EDTA 
for 1 h 30 min. Genomic L>NA inserts were digested 
at  37°C for 18 h with 50 U of XbaI following the 
recommendations of the manufacturer (Boehringer 
Mannheim, Germany). After digestion, the DNA 
blocks were loaded into slots of a 1% agarose gel 
(Agarose NA, Pharmacia-Biotech, Uppsala, Sweden). 
Macrorestriction fragments were separated by pulsed- 
field gel electrophoresis (PFGE) using a contour 
clamped homogeneous electric field (CHEF MAPPER, 
BioKad, USA). PFGE was carried out at 14°C for 24 
h at 4.5 V/cm. The pulse time ranged from 6.75 to 
40.7 s. Molecular size markers included lambda DNA 
concatemers (Pharmacia-Biotech, Uppsala, Sweden). 
Gels were stained with ethidium bromide (0.05%). 
photographed under UV light and interpreted 
following the criteria described by Tenover et a1 [16]. 
RESULTS 
MICs of the 10 ESBL-producing K. pneirrnoniae mains 
and their interpretation according to the Antibiograni 
Committee of the French Society for Microbiology 
breakpoints are reported in Table 1 171. By isoelectric 
focusing of P-lactamases on polyacrylaniide gel, five 
types of strain were isolated: six strains (AKN, LIEL. 
JOL, PAJ, BET, VAN) producing TEM-3 (CTX-1) 
(PI = 6.3) = ESBL; three strains (DHA, SCA, HOC) 
with SHV-4 (CAZ-5) (PI  = 7.8) = ESBL; and one 
strain (LEM) producing two P-lactamases, TEM-1 
(PI = 5.4) and SHV-5 (CAZ-4) (PI = 8.2) = ESBL. All 
the strains produced the chromosomal SHV-1 p- 
lactamases, and strains BET, VAN and H O C  produced 
TEM-2 (PI = 5.6). The 10 K. pncrrrnoniae strains 
produced an AAC(6’)-I using 12 aminoglycosides from 
Table 1 MICs of the 10 K. pnertrnonine ESBLq and interpretation according to the Antibiogram Conmmittec of the French 
Society for Microbiology breakpoints 
MIC (mg/L) arid interprrtdtion for strain5 
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Figure 1 K. pneumoniae pulsotypes obtained after XbaI digestion. Lanes 2, 4 and 6: strains ARN, ARN* (blood culture 
strain) and VAN (pulsotype A). Lanes 1, 3, 5 and 10: strains BET, HOC, PAJ and DEL (pulsotype B). Lane 7: strain DHA 
(pulsotype C). Lanes 8 and 9: strains JOL and LEM (pulsotype D). Lane 11: strain SCA (pulsotype E). Lane 12: lambda 
DNA concatemers. 
the kit described by Miller et ail [12]. Moreover, SCA 
and HOC also harbored an AAC(3)-I + APH(3')-II. 
Among the 10 isolates of K. pneumoniae, five 
pulsotypes (A-E) (Figure 1) were obtained by PFGE 
analysis. This analysis revealed the heterogeneous 
origin of the strains: the same pulsotype was sometimes 
found in dfferent wards but, in these cases, the PIS of 
the ESBLs were not the same or the dates of isolation 
were different. These results are summarized in Table 2. 
The results of the killing curves showed that IMP 
alone, as well as combinations of IMP and SUL, gave a 
bactericidal effect within 6 h; when an aminoglycoside 
was added, this effect was obtained within 3 h with 
AKN, and within 1 h with ISE (Figure 2a). The 
two cephalosporins alone decreased the inoculum of 
4 loglo at 6 h but regrowth was observed at 24 h. The 
combinations of cephalosporins (FEP or CPO) with 
SUL were bactericidal, with a 4 loglo decrease being 
Table 2 Origins, pulsotypes and ESBLs of the 10 K. pneumoniae strains 
Strain Unit of 
(N = 10) isolation 
Origin of strain 
(date of isolation) 
Pulsotype 
XbaI ESBL/pI 
ARN ' 
BET 
IIHA 
DEL 
HOC 
JOL 
WJ 
LEM 
SCA 
VAN 
ICU 
Emergency 
Emergency 
ICU 
ICU 
ICU 
Nephrology 
ICU 
Cardiology 
Emergency 
Urine (December 1994) 
Nasal specimen (April 1994) 
Catheter (July 1994) 
Tracheal aspiration (December 1994) 
Urine Uanuary 1995) 
Stool (April 1994) 
Tracheal aspiration (April 1994) 
Tracheal aspiration (December 1994) 
Urine (December 1994) 
Catheter (July 1994) 
A 
B 
C 
B 
B 
D 
D 
B 
E 
A 
TEM-3/63 
TEM-3/6.3 
SHV-4/7.8 
TEM-3/6.3 
SHV-4/73 
TEM-3/6.3 
SHV-5/8.2 
TEM-3/6.3 
SHV-4/7.8 
TEM-3/6.3 
" A  second isolate of K pneumonrae froin a blood culture was obtamed and studied by PFGE 
ICU, intensive care unit 
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Loglo CFU/mL 
(4 
10 
9 
8 
7 
6 
6 
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3 
2 
1 
.-f- IMP + SUL 
+ IMP + AKN 
+ IMP + ISE 
-f- IMP + SUL + AKN 
2 h  6 h  24 h 
& Control 
+ FEP 
 FEP + SUL 
Jt FEP +AKN + FEP + ISE 
-0- FEP + SUL + AKN 
1 - -  
1 
Oh l h  3 h  6 h  24 h 
lo  T 
Oh l h  3 h  6 h  24 h 
Figure 2 (a) Mean killing curvcb of IMP, IMP + SUL, IMP + AKN, IMP + ISE, IMP + SUL + AKN and IMP + SUL + 
ISE at clinically achievable concentrations. (b) Mean killing curves of FEP, FEP + SUL, FEP + AKN, FEP + ISE, FEP + 
SUL + AKN and FEP + SUL + ISE at clinically achievable concentrations. (c) Mean lulling curves of CPO, C P O  + SUL, 
CPO + AKN, C P O  + ISE, C P O  + SUL + AKN and C P O  + SUL + ISE at clinically achievable concentrations. 
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obtained within 6 h, without regrowth at 24 h. All 
cephalosporin combinations were bactericidal within 
6 h with AKN, and within 3 h with ISE, without 
regrowth at 24 h (Figure 2b,c). 
DISCUSSION 
ESBLs are new broad-spectrum 0-lactamases mainly 
produced by K. pneumoniae, and are widespread every- 
where. They increase bacterial resistance to p-lactam 
antibiotics, with the exception of carbapenems and 
compounds with C6 or C 7 a  methoxy substituents. 
Other Enterobacteriaceae, such as Salmonella spp., 
Escheviclzia coli, Citvobacterfreundii, Eutevobacter spp. and 
I’rotetrs mirubilis, can also harbor these new enzymes 
[ 17-19]. P-Lactamase inhibitors are effective against 
these enzymes and have potential therapeutic value. 
MICs of the new broad-spectrum cephalosporins, 
FEP and CPO, against ESBL-producing K. pneumoniae 
strains are lower than those of the other cephalosporins, 
classifying these strains as susceptible [20,21]. The 
bacteriostatic study does not prcmide adequate infornia- 
tion to advise physicians on ,antibiotic prescription, 
given that these p-lactam antibiotics are partially 
hydrolyzed by ESBLs. The killing-curve method 
appears more suitable for studying synergistic inter- 
actions between p-lactams and p-lactani inhibitors 
in the presence and absence of an aminoglycoside, 
providing a rapid warning for the physician. Thus, the 
results of this study show that IMP, FEP + SUL and 
<:PO + SUL give a bactericidal effect with a 4 loglo 
decrease obtained within 6 h without regrowth at 
24 h on the 10 K. ptzeirmoniae strains producing 
different ESBLs. These results were obtained with 
antibiotic regimens which can be achieved in vivo. An 
added aminoglycoside (AKN ‘or ISE), increasing the 
bactericidal rate of such combinations, is a considerable 
advantage, as it decreases the required inoculum of 
these strains, avoiding the inoculum effect potentially 
found in vivo. Although the M[Cs of AKN are low for 
the 10 strains, an AAC(6’)-I is present in the ESBL- 
producing K. pneumoniae strains, precluding the pre- 
scription of this aminoglycoside. In our study, AKN 
was active in combination with the cephalosporin, 
increasing the bactericidal effect within 6 h: this activity 
is comparable to the decrease achieved with ISE parti- 
ally protected from hydrolysis by the AAC(6’)-I. This 
effect of AKN versus ISE has also been described 
by Chidiac et a1 [22] in an experimental model of 
pneumonia with an AAC(6’)-1 Pseudomoizas aeruginosa 
strain, showing a similar pulmonary bacterial clearance 
at 6 h with AKN and ISE. The experimental models 
also give more information about the 0-lactam activity: 
Rice et a1 [23] showed, in a rat intra-abdominal abscess 
model, the inoculum effect of the ESBL-producing K. 
pneumoniae strains on the extended-spectrum cephalo- 
sporins. Among those, cefoperazone + SUL has the 
best bactericidal activity against an inoculum of 
lo5 CFU/mL, but is susceptible to the inoculum effect: 
with an inoculum of 10’ CFU/niL, the authors suggest 
that the bactericidal effect of the combination is altered. 
Thus, the antibiotic approach by the bactericidal killing- 
curve technique shows that the combinations FEP + 
SUL and CPO + SUL are an alternative to IMP, 
allowing a cycling of antibiotics, thus avoiding the 
emergence of resistant strains [24]. To conclude, it may 
be prudent to avoid extended-spectrum cephalosporins 
as a single agent when treating serious infections due 
to ESBL-producing K. pneumoniae strains [25]. The 
addition of a P-lactamase inhibitor such as SUL k 
aminoglycoside is advisable to avoid failure of treat- 
ment. These results are expected to be confirmed with 
the experimental model of pneumonia [26]. 
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